SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-20-000168
Filing Date
2020-05-06
Accepted
2020-05-06 17:27:01
Documents
1
Group Members
ARCH VENTURE FUND X OVERAGE, L.P.ARCH VENTURE PARTNERS VI, L.P.ARCH VENTURE PARTNERS VI, LLCARCH VENTURE PARTNERS X OVERAGE, L.P.ARCH VENTURE PARTNERS X, LLCCLINTON BYBEEKEITH CRANDELLKRISTINA BUROWROBERT NELSENSTEVEN GILLIS

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VI, L.P. / VBI VACCINES, INC. - SCHEDULE 13DA2 archvi-vbi.htm SC 13D/A 377057
  Complete submission text file 0001072613-20-000168.txt   379117
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Subject) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-41542 | Film No.: 20853746
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 8755 W HIGGINS RD STE 1025 CHICAGO IL 60631
Business Address 8755 W HIGGINS RD STE 1025 CHICAGO IL 60631 7733806600
ARCH VENTURE FUND VI LP (Filed by) CIK: 0001222135 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A